The U.S. Food and Drug Administration (FDA) announced plans to implement changes to its medical device clearance process that would rely far less on older predicate devices and offer a modernized pathway for high-tech medical innovations. The changes represent a significant shift in the way the FDA approves devices for marketing in the U.S., a process first introduced more than 40 years ago. Specifically, the agency plans to change the 510(k) pathway required for new medical devices to account for advances in medical technology. Read more here.
PYA Webinar on “So You Have a PPP Loan. Now What?”
- Jun 03 2020
Sky City "Virtual Happy Hour"
- Jun 04 2020
Innov865 Alliance Webinar with Knoxville Mayor Indya Kincannon
- Jun 24 2020
First Virtual Session: Tennessee Valley Corridor "National Summit"
- Jul 16 2020
Second Virtual Session: Tennessee Valley Corridor "National Summit"
- Jul 23 2020